Insider · CIK 0001342826
Erck Stanley C
Reports to the SEC for 4 companies · ROCKVILLE, MD
Transactions
50
Companies
4
Filings
6
CIK
0001342826
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-17 | MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award | — |
| 2026-06-17 | MXCTMAXCYTE, INC.A Award | — |
| 2025-08-13 | MXCTMAXCYTE, INC.P Purchase | +$137K |
| 2025-06-18 | MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award | — |
| 2025-06-18 | MXCTMAXCYTE, INC.A Award | — |
| 2024-11-01 | MXCTMAXCYTE, INC.M Exercise/Conversion | +$1,907.56 |
| 2024-11-01 | MXCTMAXCYTE, INC.S Sale | −$177K |
| 2024-11-01 | MXCTMAXCYTE, INC. · Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-10-02 | MXCTMAXCYTE, INC.S Sale | −$80.2K |
| 2024-10-02 | MXCTMAXCYTE, INC. · Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-10-02 | MXCTMAXCYTE, INC.M Exercise/Conversion | +$864.28 |
| 2024-10-01 | MXCTMAXCYTE, INC.S Sale | −$98.6K |
| 2024-10-01 | MXCTMAXCYTE, INC.M Exercise/Conversion | +$1,043.28 |
| 2024-10-01 | MXCTMAXCYTE, INC. · Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-09-04 | MXCTMAXCYTE, INC.M Exercise/Conversion | +$1,190.68 |
| 2024-09-04 | MXCTMAXCYTE, INC. · Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-09-04 | MXCTMAXCYTE, INC.S Sale | −$118K |
| 2024-09-03 | MXCTMAXCYTE, INC.S Sale | −$73.5K |
| 2024-09-03 | MXCTMAXCYTE, INC.M Exercise/Conversion | +$716.88 |
| 2024-09-03 | MXCTMAXCYTE, INC. · Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-06-11 | MXCTMAXCYTE, INC.A Award | — |
| 2024-06-11 | MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award | — |
| 2023-06-22 | MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award | — |
| 2022-12-14 | NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion | — |
| 2022-12-14 | NVAXNOVAVAX INCF Tax Payment | −$40K |
| 2022-12-14 | NVAXNOVAVAX INCM Exercise/Conversion | — |
| 2022-09-26 | NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion | — |
| 2022-09-26 | NVAXNOVAVAX INCF Tax Payment | −$41.1K |
| 2022-09-26 | NVAXNOVAVAX INCM Exercise/Conversion | — |
| 2022-06-29 | MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award | — |
| 2022-03-10 | NVAXNOVAVAX INC · Stock Option (Right to Buy)A Award | — |
| 2022-03-10 | NVAXNOVAVAX INC · Restricted Stock UnitsA Award | — |
| 2021-12-14 | NVAXNOVAVAX INCM Exercise/Conversion | — |
| 2021-12-14 | NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion | — |
| 2021-12-14 | NVAXNOVAVAX INCF Tax Payment | −$567K |
| 2021-10-04 | NVAXNOVAVAX INCM Exercise/Conversion | +$883K |
| 2021-10-04 | NVAXNOVAVAX INCS Sale | −$232K |
| 2021-10-04 | NVAXNOVAVAX INCM Exercise/Conversion | +$292K |
| 2021-10-04 | NVAXNOVAVAX INC · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-10-04 | NVAXNOVAVAX INCS Sale | −$90.3K |
| 2021-10-04 | NVAXNOVAVAX INC · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-10-04 | NVAXNOVAVAX INCS Sale | −$829K |
| 2021-10-04 | NVAXNOVAVAX INCS Sale | −$1.58M |
| 2021-10-04 | NVAXNOVAVAX INCS Sale | −$632K |
| 2021-10-04 | NVAXNOVAVAX INCS Sale | −$1.53M |
| 2021-10-04 | NVAXNOVAVAX INCS Sale | −$646K |
| 2021-10-04 | NVAXNOVAVAX INCS Sale | −$874K |
| 2021-10-04 | NVAXNOVAVAX INCS Sale | −$541K |
| 2021-10-04 | NVAXNOVAVAX INCS Sale | −$592K |
| 2021-10-01 | NVAXNOVAVAX INCS Sale | −$116K |
Recent filings
- 4Erck Stanley C0000905148-26-003054SEC(opens sec.gov)
- 4Erck Stanley C0000905148-25-002875SEC(opens sec.gov)
- 4Erck Stanley C0000905148-25-002233SEC(opens sec.gov)
- 4Erck Stanley C0001415889-24-026144SEC(opens sec.gov)
- 4Erck Stanley C0001415889-24-024454SEC(opens sec.gov)
- 4Erck Stanley C0001415889-24-022941SEC(opens sec.gov)
Companies
Address
C/O MAXCYTE, INC. 9713 KEY WEST AVENUE, SUITE 400
ROCKVILLE, MD, 20850